PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE— 510(k) K770453
Substantially EquivalentIcn Pharmaceuticals, Inc.
FDA 510(k) clearance K770453 for PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE, Substantially Equivalent on 1977-05-03. Applicant: Icn Pharmaceuticals, Inc.. Device class: 2.
Clearance details
- Applicant
- Icn Pharmaceuticals, Inc.
- Product code
- Code CIO
- Device class
- Class 2
- Regulation
- 21 CFR 862.1050
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Orangeburg, NY, US
Recent devices under product code CIO
view allMore clearances from Icn Pharmaceuticals, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.